1. Home
  2. VRCA vs VNCE Comparison

VRCA vs VNCE Comparison

Compare VRCA & VNCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRCA
  • VNCE
  • Stock Information
  • Founded
  • VRCA 2013
  • VNCE 2002
  • Country
  • VRCA United States
  • VNCE United States
  • Employees
  • VRCA N/A
  • VNCE N/A
  • Industry
  • VRCA Biotechnology: Pharmaceutical Preparations
  • VNCE Clothing/Shoe/Accessory Stores
  • Sector
  • VRCA Health Care
  • VNCE Consumer Discretionary
  • Exchange
  • VRCA Nasdaq
  • VNCE Nasdaq
  • Market Cap
  • VRCA 32.7M
  • VNCE 33.9M
  • IPO Year
  • VRCA 2018
  • VNCE 2013
  • Fundamental
  • Price
  • VRCA $3.77
  • VNCE $2.67
  • Analyst Decision
  • VRCA Hold
  • VNCE Strong Buy
  • Analyst Count
  • VRCA 2
  • VNCE 4
  • Target Price
  • VRCA N/A
  • VNCE $4.63
  • AVG Volume (30 Days)
  • VRCA 247.5K
  • VNCE 115.0K
  • Earning Date
  • VRCA 11-06-2025
  • VNCE 12-09-2025
  • Dividend Yield
  • VRCA N/A
  • VNCE N/A
  • EPS Growth
  • VRCA N/A
  • VNCE N/A
  • EPS
  • VRCA N/A
  • VNCE N/A
  • Revenue
  • VRCA $14,704,000.00
  • VNCE $291,286,000.00
  • Revenue This Year
  • VRCA $332.45
  • VNCE $1.48
  • Revenue Next Year
  • VRCA $12.85
  • VNCE $4.92
  • P/E Ratio
  • VRCA N/A
  • VNCE N/A
  • Revenue Growth
  • VRCA 5.72
  • VNCE N/A
  • 52 Week Low
  • VRCA $3.28
  • VNCE $1.02
  • 52 Week High
  • VRCA $13.60
  • VNCE $6.89
  • Technical
  • Relative Strength Index (RSI)
  • VRCA 44.18
  • VNCE 44.48
  • Support Level
  • VRCA $3.37
  • VNCE $2.34
  • Resistance Level
  • VRCA $3.99
  • VNCE $2.91
  • Average True Range (ATR)
  • VRCA 0.25
  • VNCE 0.16
  • MACD
  • VRCA 0.03
  • VNCE -0.04
  • Stochastic Oscillator
  • VRCA 45.12
  • VNCE 47.01

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

Share on Social Networks: